CONSOLIDATED STATEMENT OF CASH FLOWS (unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (602,229)	$ (201,441)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	7,248	6,380
Loss on deferred financing costs	120,019	30,160
Non-cash gain on exchange of equity investment	(26,660)	(40,953)
Non-cash fair value of common stock issued as compensation	21,000	30,000
Interest receivable	(4,175)	(11,085)
Loss on impairment	4,175	11,085
Non-cash fair value of common stock issued with notes payable	63,760
Loss on issuance of common stock in exchange for interest settlement on notes payable	62,150	16,850
(Increase) Decrease in:
Accounts receivable	917	1,997
Inventories	1,532	488
Prepaid expenses	(3,253)	(8,845)
Increase (decrease) in:
Accounts payable	121,661	(7,124)
Accrued interest and expenses	6,943	49,966
Net Cash Used by Operating Activities	(226,912)	(122,522)
CASH FLOWS FROM INVESTING ACTIVITIES:
Payments received on note receivable	90,000	50,000
Net Cash (Used) provided by Investing Activities	90,000	50,000
CASH FLOWS FROM FINANCING ACTIVITIES
Cash provided by Notes Payable	386,000	64,000
Net Cash provided from financing activities	386,000	64,000
Net Increase (Decrease) in Cash and Cash Equivalents	249,088	(8,522)
Cash and Cash Equivalents, Beginning of Period	4,457	9,989
Cash and Cash Equivalents, End of Period	253,545	1,467
Supplemental Cash Flow Disclosures:
Interest expense paid in cash
Income tax paid
NON CASH INVESTING & FINANCING ACTIVITIES
Shares issued for accounts payable		$ 9,000